Analgesics and breast-feeding: Safety considerations

Paediatric Drugs

Volumn 2, Issue 3, 2000, Pages 223-238

  Spigset, Olav ^a   Hägg, Staffan ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; FENTANYL DERIVATIVE; IBUPROFEN; INDOMETACIN; KETOBEMIDONE; MORPHINE DERIVATIVE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PETHIDINE; PIROXICAM; TENOXICAM;

ANALGESIA; AREA UNDER THE CURVE; BREAST FEEDING; CALCULATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG TRANSFORMATION; PAIN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; URINARY EXCRETION;

EID: 0034082392     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200002030-00006     Document Type: Review

References (100)

1. 1. Dewey KG, Heinig MJ, Nommsen-Rivers LA. Differences in morbidity between breast-fed and formula-fed infants. J Pediatr 1995; 126: 696-702
2. 2. Ford K, Labbok M. Breast-feeding and child health in the United States. J Biosoc Sci 1993; 25: 187-94
3. 3. Wright AL, Holberg CJ, Martinez FD, et al. Breast-feeding and lower respiratory tract illness in the first year of life. BMJ 1989; 299: 946-9
4. 4. Pisacane A, Graziano L, Mazzarella G, et al. Breast-feeding and urinary tract infection. J Pediatr 1992; 120: 87-9
5. 5. Saarinen UM, Kajosaari M, Backman A, et al. Prolonged breast-feeding as prophylaxis for utopic disease. Lancet 1979; 11: 163-8
6. 6. Hahn-Zoric M, Fulconis F, Minoli I, et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr Scand 1990; 79: 1137-42
7. 7. Riordan JM. The cost of not breastfeeding: a commentary. J Hum Lact 1997; 13: 93-7
8. 8. Ball TM, Wright AL. Health care costs of formula-feeding in the first year of life. Pediatrics 1999; 103: 870-6
9. 9. Byers T, Graham S, Rzepka T, et al. Lactation and breast cancer: evidence for a negative association in premenopausal women. Am J Epidemiol 1985; 121: 664-74
10. 10. Spigset O, Hägg S. Excretion of psychotropic drugs into breast milk. CNS Drugs 1998; 9: 111-34
11. 11. Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998; 45: 525-38
12. 12. Yue QY, Hasselström J, Svensson JO, et al. Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparison between extensive and poor metabolisers of debrisoquine. Br J Clin Pharmacol 1991; 31: 635-42
13. 13. Bertilsson L. Geographic/interracial differences in polymorphic drug oxidation. Clin Pharmacokinet 1995; 29: 192-209
14. 14. Casey C, Hambridge KM. Nutritional aspects of human lactation. In: Neville MC, Neifert MR, editors. Lactation: physiology, nutrition and breast-feeding. New York (NY): Plenum Press, 1983: 199-248
15. 15. Öhman R, Hägg S, Carleborg L, et al. Excretion of paroxetine into breast milk. J Clin Psychiatry 1999; 60: 519-23
16. 16. Prentice A, Prentice AM, Whitehead RG. Breast-milk fat concentrations of rural African women: short-term variations within individuals. Br J Nutr 1981; 45: 483-94
17. 17. Bennett PN. Drugs and human lactation. 2nd ed. Amsterdam: Elsevier, 1996
18. 18. Wilson JT, Brown DJ, Hinson JL, et al. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Annu Rev Pharmacol Toxicol 1985; 25: 667-89
19. 19. Anderson PO. Drugs and breast-feeding. Semin Perinatol 1979; 3: 271-8
20. 20. Gourley GR, Arend RA. β-Glucuronidase and hyperbilirubinaemia in breast-fed and formula-fed babies. Lancet 1986; I: 644-6
21. 21. Morselli PL. Clinical pharmacokinetics in neonates. Clin Pharmacokinet 1976; 1: 81-9
22. 22. Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants. Clin Pharmacokinet 1980; 5: 485-527
23. 23. Mammen GJ, editor. Clinical pharmacokinetics: drug data handbook. 2nd ed. Auckland: Adis Press Limited, 1990
24. 24. Kanto J. Risk-benefit assessment of anaesthetic agents in the puerperium. Drug Saf 1991; 6: 285-301
25. 25. Rane A. Drug disposition and action in infants and children. In: Yaffe SJ, Aranda JV, editors. Pediatric pharmacology. 2nd ed. Philadelphia (PA): W.B. Saunders, 1992: 10-21
26. 26. Gauntlett IS, Fisher DM, Hertzka RE, et al. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988; 69: 683-7
27. 27. Levy G, Garettson LK. Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics 1974; 53: 201-10
28. 28. Jopkins CS, Underhill S, Booker PD. Pharmacokinetics of paracetamol after cardiac surgery. Arch Dis Child 1990; 65: 971 -6
29. 29. Traeger A, Nöschel H, Zaumseil J. Zur Pharmakokinetik von Indomethazin bei Schwangeren, Kreissenden und deren Neugeborenen. Zentralbl Gynaekol 1973; 95: 635-41
30. 30. Blumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV, editors. Pediatric pharmacology. 2nd ed. Philadelphia (PA): W.B. Saunders, 1992: 164-77
31. 31. Kanto JH. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 1982; 23: 354-80
32. 32. Notarianni LJ, Oldham HG, Bennett PN. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol 1987; 24: 63-7
33. 33. Bitzén P-O, Gustafsson B, Jostell KG, et al. Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol 1981; 20: 123-5
34. 34. Berlin Jr CM, Yaffe SJ, Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. Pediatr Pharmacol 1980; 1: 135-41
35. 35. Matheson I, Lunde PKM, Notarianni L. Infant rash caused by paracetamol in breast milk? Pediatrics 1985; 76: 651-2
36. 36. Findlay JWA, DeAngelis RL, Kearney MF, et al. Analgesic drugs in milk and plasma. Clin Pharmacol Ther 1981; 29: 625-33
37. 37. Ito S, Blajchman A, Stephenson M, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993; 168: 1393-9
38. 38. Kwit NT, Hatcher RA. Excretion of drugs in milk. Am J Dis Child 1935; 49: 900-4
39. 39. Bailey DN, Weibert RT, Naylor AJ, et al. A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol 1982; 6: 64-8
40. 40. Erickson SH, Oppenheim GL. Aspirin in breast milk. J Fam Pract 1979; 8: 189-90
41. 41. Jamali F, Keshavarz E. Salicylate excretion in breast milk. Int J Pharmacol 1981; 8: 285-90
42. 42. Pütter J, Satravaha P, Stockhausen H. Quantitative Bestimmung der Hauptmetaboliten der Acetylsalizylsäure. Vergleichende Bestimmung in Blut und Milch von Stillenden Frauen. Z Geburtshilfe Perinatol 1974; 178: 135-8
43. 43. Pütter J. Übersicht über die Pharmakokinetik der Acetylsalizylsäure. Med Welt 1976; 27: 1362-5
44. 44. Needs CJ, Brooks PM. Antirheumatic medication during lactation. Br J Rheumatol 1985; 24: 291-7
45. 45. Stuart MJ, Gross SJ, Elrad H, et al. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982; 307: 909-12
46. 46. Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr (Phila) 1981; 20: 53-4
47. 47. Unsworth J, d'Assis Fonseca A, Beswick DT, et al. Serum salicylate levels in a breast fed infant. Ann Rheum Dis 1987; 46: 638-9
48. 48. Terragna A, Spirito L. Porpora trombocitopenica in lattante dopo somministrazione di acido acetilsalicilico alla nutrice. Minerva Pediatr 1967; 19: 613-6
49. 49. Butler D. Infantile colic and aspirin [letter]. Med J Aust 1987; 146: 179
50. 50. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93: 137-50
51. 51. Byron MA. Prescribing in pregnancy: treatment of rheumatic diseases. BMJ 1987; 294: 236-8
52. 52. Schoenfeld A, Bar Y, Merlob P, et al. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 1992; 28: 141-7
53. 53. Berlin CM. Drugs and chemicals: exposure of the nursing mother. Pediatr Clin North Am 1989; 36: 1089-97
54. 54. Anderson PO. Drug use during breast-feeding. Clin Pharm 1991; 10: 594-624
55. 55. Bald R, Bernbeck-Betthäuser EM. Spahn H, et al. Excretion of azapropazone in human breast milk. Eur J Clin Pharmacol 1990; 39: 271-3
56. 56. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988; 35: 244-85
57. 57. Zylber-Katz E, Linder N, Granit L, et al. Excretion of dipyrone metabolites in human breast milk. Eur J Clin Pharmacol 1986; 30: 359-61
58. 58. Dell HD, Fiedler J. Prüfung der Elimination von Etofenamat in die Milch. Arch Pharm Weinheim 1983; 316: 746-51
59. 59. Chiccarelli FS, Eisner HJ, Van Lear GE. Metabolic and pharmacokinetic studies with fenbufen in man. Arzneimittelforschung 1980; 30: 728-35
60. 60. Buchanan RA, Eaton CJ, Koeff ST, et al. The breast milk excretion on flufenamic acid. Curr Ther Res Clin Exp 1969; 11: 533-8
61. 61. Smith IJ, Hinson JL, Johnson VA, et al. Flurbiprofen in postpartum women: plasma and breast milk disposition. J Clin Pharmacol 1989; 29: 174-84
62. 62. Cox SR, Forbes KK. Excretion of flurbiprofen into breast milk. Pharmacotherapy 1987; 7: 211-5
63. 63. Townsend RJ, Benedetti TJ, Erickson SH, et al. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 1984; 149: 184-6
64. 64. Weibert RT, Townsend RJ, Kaiser DG, et al. Lack of ibuprofen secretion into human milk. Clin Pharm 1982; 1: 457-8
65. 65. Walter K, Dilger C. Ihuprofen in human milk. Br J Clin Pharmacol 1997; 44: 211-2
66. 66. Lebedevs TH, Wojnar-Horton RE, Yapp P. et al. Excretion of indomethacin in breast milk. J Clin Pharmacol 1991; 32: 751-4
67. 67. Wischnik A, Manth SM, Lloyd J, et al. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 1989; 36: 521-4
68. 68. Huber R, Zech K, Dittmann EC, et al. Pharmacokinetics of the antirheumatic Ionazolac-Ca in humans [in German], Arzneimittelforschung 1990; 40: 918-25
69. 69. Buchanan RA, Eaton CJ, Koeff ST, et al. The breast milk excretion of mefenamic acid. Curr Ther Res Clin Exp 1968; 10: 592-7
70. 70. Jamali F, Stevens DR. Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm 1983; 17: 910-1
71. 71. Brogden RN, Pinder RM, Sawyer PR, et al. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 1975; 9: 326-63
72. 72. Östensen M, Matheson I, Laufen H. Piroxicam in breast milk after long-term treatment. Eur J Clin Pharmacol 1988; 35: 567-9
73. 73. Östensen M. Piroxicam in human breast milk. Eur J Clin Pharmacol 1983; 25: 829-30
74. 74. Knowles JA. Excretion of drugs in milk: a review. J Pediatr 1965; 66: 1068-82
75. 75. Heintz RC, Stebler T, Lunell O, et al. Excretion of tenoxicam and 5-hydroxy-tenoxicam into human milk. J Pharm Med 1993; 3: 57-64
76. 76. Sagraves R, Waller ES, Goehrs HR. Tolmetin in breast milk. Drug Intell Clin Pharm 1985; 19: 55-6
77. 77. Goldsmith DP. Neonatal rheumatic disorders: view of the pediatrician. Rheum Dis Clin North Am 1989; 15: 287-305
78. 78. Rizzoni G, Furlanut M. Cyanotic crises in a breast-fed infant from mother taking dipyrone. Hum Toxicol 1984; 3: 505-7
79. 79. Eeg-Olofsson O, Malmros I, Elwin CE, et al. Convulsions in a breast-fed infant after maternal indomethacin [letter]. Lancet 1978; II: 215
80. 80. Fairhead FW. Convulsions in a breast-fed infant after maternal indomethacin [letter]. Laneet 1978; II: 576
81. 81. Fidalgo I, Correa K, Gomez-Carrasco JA, et al. Anemia aguda, rectorragia y hematuria asociadas a la ingestion de naproxen. An Esp Pediatr 1989; 30: 317-9
82. 82. Pittman KA, Smyth RD, Losada M, et al. Human perinatal distribution of butorphanol. Am J Obstet Gynecol 1980; 138: 797-800
83. 83. Meny RG, Naumburg EC, Alger LS, et al. Codeine and the breastfed neonate. J Hum Lact 1993; 9: 237-40
84. 84. Steer PL, Biddle CJ, Marley WS, et al. Concentration of fentanyl in colostrum after an analgesic dose. Can J Anesth 1992; 39: 231-5
85. 85. Leuschen MP, Wolf LJ, Rayburn WF. Fentanyl excretion in breast milk. Clin Pharm 1990: 9: 336-7
86. 86. Gerdin E, Bondesson U, Hartvig P. Excretion of ketobemidone in human breast milk. J Perinat Med 1996; 24: 293-5
87. 87. Feilberg VL, Rosenborg D, Christensen CB, et al. Excretion of morphine in human breast milk. Acta Anaesthesiol Scand 1989; 33: 426-8
88. 88. Wittels B, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology 1990: 73: 864-9
89. 89. Peiker G, Müller B, Ihn W, et al. Ausscheidung von Pethidin durch die Muttermilch. Zbl Gynaekol 1980: 102: 537-41
90. 90. Quinn PG, Kuhnert BR, Kaine CJ, et al. Measurement of meperidine and normeperidine in human breast milk by selected ion monitoring. Biomed Environ Mass Spectrom 1986; 13: 133-5
91. 91. Borgatta L, Jenny RW, Gruss L, et al. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol 1997; 37: 186-92
92. 92. Kunka RL, Venkataramanan R, Stern RM, et al. Excretion of propoxyphene and norpropoxyphene in breast milk. Clin Pharmacol Ther 1984; 35: 675-80
93. 93. Kunka RL, Yong C-L, Ladik CE, et al. Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk. S Pharm Sci 1985; 74: 103-4
94. 94. Robieux I, Koren G, Vandenbergh H, et al. Morphine excretion in breast milk and resultant exposure of a nursing infant. J Toxicol Clin Toxicol 1990; 28: 365-70
95. 95. Sindrup SH, Broøsen K. The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995; 5: 335-46
96. 96. Lynn AM, Opheim KE, Tyler DC. Morphine infusion after pediatric cardiac surgery. Crit Care Med 1984; 12: 863-6
97. 97. Olkkola KT, Maunuksela EL, Korpela R, et al. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 1988; 44: 128-36
98. 98. Terwilliger WG, Hatcher RA. The elimination of morphine and quinine in human milk. Surg Gynecol Obstet 1934; 58: 823-6
99. 99. Wittels B, Glosten B, Faure EAM, et al. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia: neurobehavioral outcomes among nursing neonates. Anesth Analg 1997; 85: 600-6
100. 100. Koren G, Levy M. Opioid uses in children. Pediatr Clin North Am 1989; 36: 1141-55